Filing Flows › Arteris (AIP) › R&D spending
Arteris (AIP) R&D spending by quarter
Arteris' R&D spending was $16.4M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $11.9M (Q1 2025) to $16.8M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.4M | -2% | +30% |
| Q2 2026 | $16.8M | +16% | +38% |
| Q1 2026 | $14.5M | +9% | +22% |
| Q4 2025 | $13.2M | +5% | — |
| Q3 2025 | $12.6M | +4% | — |
| Q2 2025 | $12.2M | +3% | — |
| Q1 2025 | $11.9M | — | — |
Q3 2026 at a glance
Arteris, Q3 2026: revenue $25.8M (+48% year over year), operating margin -43.9%, net loss $11.2M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arteris' R&D spending?
Arteris' R&D spending was $16.4M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Arteris' R&D spending changed?
Over the last 7 quarters it ranged from $11.9M (Q1 2025) to $16.8M (Q2 2026).